JG
STJ

Jefferies Group’s St Jude Medical STJ Stock Holding History

Jefferies Group’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-119,600
Closed -$9.59M – 2871
2016
Q4 		$9.59M Sell
119,600
-666,000
-85% -$52.9M 0.05% 358
2016
Q3 		$62.7M Buy
+785,600
New +$63.4M 0.32% 39
2015
Q2 		– Sell
-99,400
Closed -$6.5M – 3626
2015
Q1 		$6.5M Buy
+99,400
New +$6.61M 0.04% 344

Other funds holding STJ

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Jefferies Group's STJ Position: Q1 2017 in Review

Jefferies Group sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 14,700 shares — an estimated $1.18M sold.

Jefferies Group first reported a position in STJ in Q4 2013 and held it in 12 quarters. The position peaked at $21M in Q3 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Jefferies Group reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Jefferies Group sold 14,700 St Jude Medical shares in Q1 2017, an estimated $1.18M.
  • Jefferies Group first reported a position in St Jude Medical in Q4 2013 and held it in 12 quarters.
  • Jefferies Group's St Jude Medical position peaked at $21M in Q3 2016.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Jefferies Group's 13F filing for Q1 2017, filed 15 May 2017.